Using specific KCa2.3 blockers (UCL1684), Kroigaard and collaborators demonstrated that these channels contribute to endothelium-dependent relaxation, indicating that Kca2.3 channels are a potential target for pulmonary hypertensive pathology [64]. Here, KCNN3 is linked to pulmonary hypertension.